Inozyme Pharma News - INZY

Company Name	Stock Ticker Symbol	Market	Type
Inozyme Pharma Inc	INZY	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.0509	1.18%	4.3809	13:41:49

Open Price	Low Price	High Price	Close Price	Prev Close
4.33	4.23	4.51		4.33

more quote information »

Recent News

Date	Time	Source	Heading
4/08/2024	06:30	GLOBE	Inozyme Pharma Announces Positive Topline Data from Ongoing..
4/05/2024	18:00	GLOBE	Inozyme Pharma Reports Inducement Grants Under Nasdaq..
4/02/2024	08:30	GLOBE	Inozyme Pharma to Participate at the 23rd Annual Needham..
3/26/2024	08:30	GLOBE	Inozyme Pharma to Report Topline Data from Ongoing Phase 1/2..
3/12/2024	08:30	GLOBE	Inozyme Pharma Reports Full Year 2023 Financial Results and..
2/26/2024	08:30	GLOBE	Inozyme Pharma to Participate in the TD Cowen 44th Annual..
2/14/2024	08:48	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2/12/2024	21:06	EDGAR2	Form SC 13D/A - General statement of acquisition of..
2/06/2024	08:30	GLOBE	Inozyme Pharma Reports Inducement Grants Under Nasdaq..
12/05/2023	08:30	GLOBE	Inozyme Pharma Reports Inducement Grants Under Nasdaq..
11/16/2023	00:15	EDGAR2	Form EFFECT - Notice of Effectiveness
11/09/2023	08:30	GLOBE	Inozyme Pharma to Participate in Upcoming Investor..
11/07/2023	16:07	EDGAR2	Form S-3 - Registration statement under Securities Act of..
11/07/2023	08:34	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/07/2023	08:31	EDGAR2	Form 8-K - Current report
11/07/2023	08:30	GLOBE	Inozyme Pharma Reports Third Quarter 2023 Financial Results..
11/03/2023	16:15	GLOBE	Inozyme Pharma Reports Inducement Grants Under Nasdaq..
10/26/2023	08:30	GLOBE	Inozyme Pharma Announces Presentation at the American..
10/10/2023	08:30	GLOBE	Inozyme Pharma Highlights Inclusion of Generalized Arterial..
10/06/2023	08:30	GLOBE	Inozyme Pharma Announces Three Poster Presentations at the..
10/03/2023	16:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/26/2023	16:12	EDGAR2	Form 8-K - Current report
9/26/2023	07:30	GLOBE	Inozyme Pharma Announces Positive Interim Data from Ongoing..
9/20/2023	08:30	GLOBE	Inozyme Pharma to Host Virtual Investor and Analyst Event on..
9/06/2023	08:30	GLOBE	Inozyme Pharma Reports Inducement Grants Under Nasdaq..
9/05/2023	08:30	GLOBE	Inozyme Pharma to Present at the H.C. Wainwright 25th Annual..
8/11/2023	16:08	EDGAR2	Form SC 13D/A - General statement of acquisition of..
8/08/2023	09:03	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/08/2023	08:37	EDGAR2	Form 8-K - Current report
8/08/2023	08:30	GLOBE	Inozyme Pharma Reports Second Quarter 2023 Financial Results..
8/07/2023	21:58	EDGAR2	Form SC 13D/A - General statement of acquisition of..
8/03/2023	20:13	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/03/2023	16:01	GLOBE	Inozyme Pharma Reports Inducement Grants Under Nasdaq..
8/01/2023	16:01	GLOBE	Inozyme Pharma, Inc. Announces Closing of Public Offering of..
7/28/2023	17:19	EDGAR2	Form 8-K - Current report
7/28/2023	17:17	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
7/27/2023	23:20	GLOBE	Inozyme Pharma, Inc. Announces Pricing of Public Offering of..
7/27/2023	17:28	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
7/27/2023	16:33	GLOBE	Inozyme Pharma, Inc. Announces Proposed Offering of Common..
7/26/2023	07:42	EDGAR2	Form 8-K - Current report
7/26/2023	07:30	GLOBE	Inozyme Pharma Announces Updates on Global Development..
7/19/2023	08:30	GLOBE	Inozyme Pharma to Provide ENPP1 Deficiency Program Update on..
6/27/2023	08:30	GLOBE	Inozyme Pharma Announces Dosing of First Infant with ENPP1..
6/02/2023	07:30	GLOBE	Inozyme Pharma to Present at the Jefferies Healthcare..
5/09/2023	08:30	GLOBE	Inozyme Pharma Reports First Quarter 2023 Financial Results..
5/03/2023	08:30	GLOBE	Inozyme Pharma Reports Inducement Grants Under Nasdaq..